{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:45:05Z","timestamp":1782773105943,"version":"3.54.5"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-025-08092-6","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T11:48:14Z","timestamp":1749642494000},"page":"733-744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of maternal anti-Ro\/La antibodies on fetal atrioventricular conduction evaluated with echocardiography: a state-of-the-art review"],"prefix":"10.1007","volume":"312","author":[{"given":"Ya-Ting","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-Bin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"8092_CR1","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrrheum.2015.29","volume":"11","author":"P Brito-Zer\u00f3n","year":"2015","unstructured":"Brito-Zer\u00f3n P, Izmirly PM, Ramos-Casals M et al (2015) The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol 11:301\u2013312. https:\/\/doi.org\/10.1038\/nrrheum.2015.29","journal-title":"Nat Rev Rheumatol"},{"key":"8092_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/sji.12995","volume":"93","author":"A Ambrosi","year":"2021","unstructured":"Ambrosi A, Thorlacius GE, Sonesson S-E, Wahren-Herlenius M (2021) Interferons and innate immune activation in autoimmune congenital heart block. Scand J Immunol 93:e12995. https:\/\/doi.org\/10.1111\/sji.12995","journal-title":"Scand J Immunol"},{"key":"8092_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3390\/diagnostics10070478","volume":"10","author":"MR Popescu","year":"2020","unstructured":"Popescu MR, Dudu A, Jurcut C et al (2020) A broader perspective on anti-Ro antibodies and their fetal consequences-a case report and literature review. Diagnostics (Basel) 10:478. https:\/\/doi.org\/10.3390\/diagnostics10070478","journal-title":"Diagnostics (Basel)"},{"key":"8092_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/ncprheum1018","volume":"5","author":"JP Buyon","year":"2009","unstructured":"Buyon JP, Clancy RM, Friedman DM (2009) Cardiac manifestations of neonatal lupus erythematosus: guidelines to management, integrating clues from the bench and bedside. Nat Clin Pract Rheumatol 5:139\u2013148. https:\/\/doi.org\/10.1038\/ncprheum1018","journal-title":"Nat Clin Pract Rheumatol"},{"key":"8092_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/art.11430","volume":"50","author":"RM Clancy","year":"2004","unstructured":"Clancy RM, Kapur RP, Molad Y et al (2004) Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage\/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 50:173\u2013182. https:\/\/doi.org\/10.1002\/art.11430","journal-title":"Arthritis Rheum"},{"key":"8092_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fcvm.2019.00054","volume":"6","author":"YS Qu","year":"2019","unstructured":"Qu YS, Lazzerini PE, Capecchi PL et al (2019) Autoimmune calcium channelopathies and cardiac electrical abnormalities. Front Cardiovasc Med 6:54. https:\/\/doi.org\/10.3389\/fcvm.2019.00054","journal-title":"Front Cardiovasc Med"},{"key":"8092_CR7","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/BOR.0000000000000414","volume":"29","author":"P Izmirly","year":"2017","unstructured":"Izmirly P, Saxena A, Buyon JP (2017) Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus. Curr Opin Rheumatol 29:467\u2013472. https:\/\/doi.org\/10.1097\/BOR.0000000000000414","journal-title":"Curr Opin Rheumatol"},{"key":"8092_CR8","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/s1050-1738(00)00059-1","volume":"10","author":"M Boutjdir","year":"2000","unstructured":"Boutjdir M (2000) Molecular and ionic basis of congenital complete heart block. Trends Cardiovasc Med 10:114\u2013122. https:\/\/doi.org\/10.1016\/s1050-1738(00)00059-1","journal-title":"Trends Cardiovasc Med"},{"key":"8092_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semperi.2022.151585","volume":"46","author":"M Kaplinski","year":"2022","unstructured":"Kaplinski M, Cuneo BF (2022) Novel approaches to the surveillance and management of fetuses at risk for anti-Ro\/SSA mediated atrioventricular block. Semin Perinatol 46:151585. https:\/\/doi.org\/10.1016\/j.semperi.2022.151585","journal-title":"Semin Perinatol"},{"key":"8092_CR10","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1016\/j.jacc.2010.02.042","volume":"55","author":"E Jaeggi","year":"2010","unstructured":"Jaeggi E, Laskin C, Hamilton R et al (2010) The importance of the level of maternal anti-Ro\/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 55:2778\u20132784. https:\/\/doi.org\/10.1016\/j.jacc.2010.02.042","journal-title":"J Am Coll Cardiol"},{"key":"8092_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/pd.5021","volume":"37","author":"N Kan","year":"2017","unstructured":"Kan N, Silverman ED, Kingdom J et al (2017) Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat Diagn 37:375\u2013382. https:\/\/doi.org\/10.1002\/pd.5021","journal-title":"Prenat Diagn"},{"key":"8092_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/art.42733","volume":"76","author":"JP Buyon","year":"2024","unstructured":"Buyon JP, Masson M, Izmirly CG et al (2024) Prospective evaluation of high titer autoantibodies and fetal home monitoring in the detection of atrioventricular block among anti-SSA\/Ro Pregnancies. Arthritis Rheumatol 76:411\u2013420. https:\/\/doi.org\/10.1002\/art.42733","journal-title":"Arthritis Rheumatol"},{"key":"8092_CR13","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/annrheumdis-2011-200207","volume":"71","author":"A Ambrosi","year":"2012","unstructured":"Ambrosi A, Salomonsson S, Eliasson H et al (2012) Development of heart block in children of SSA\/SSB-autoantibody-positive women is associated with maternal age and displays a season-of-birth pattern. Ann Rheum Dis 71:334\u2013340. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200207","journal-title":"Ann Rheum Dis"},{"key":"8092_CR14","doi-asserted-by":"publisher","first-page":"e803","DOI":"10.1542\/peds.2007-1659","volume":"121","author":"A Skog","year":"2008","unstructured":"Skog A, Wahren-Herlenius M, Sundstr\u00f6m B et al (2008) Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52\/SSA autoantibodies. Pediatrics 121:e803-809. https:\/\/doi.org\/10.1542\/peds.2007-1659","journal-title":"Pediatrics"},{"key":"8092_CR15","first-page":"167","volume":"33","author":"D Spence","year":"2006","unstructured":"Spence D, Hornberger L, Hamilton R, Silverman ED (2006) Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and\/or anti-La antibodies. J Rheumatol 33:167\u2013170","journal-title":"J Rheumatol"},{"key":"8092_CR16","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1177\/0961203311430512","volume":"21","author":"SAS Killen","year":"2012","unstructured":"Killen SAS, Buyon JP, Friedman DM (2012) Discordant spectrum of cardiac manifestations of neonatal lupus in twins. Lupus 21:559\u2013562. https:\/\/doi.org\/10.1177\/0961203311430512","journal-title":"Lupus"},{"key":"8092_CR17","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/j.jacc.2018.07.076","volume":"72","author":"BF Cuneo","year":"2018","unstructured":"Cuneo BF, Sonesson S-E, Levasseur S et al (2018) Home monitoring for fetal heart rhythm during anti-ro pregnancies. J Am Coll Cardiol 72:1940\u20131951. https:\/\/doi.org\/10.1016\/j.jacc.2018.07.076","journal-title":"J Am Coll Cardiol"},{"key":"8092_CR18","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1161\/01.cir.0000437597.44550.5d","volume":"129","author":"MT Donofrio","year":"2014","unstructured":"Donofrio MT, Moon-Grady AJ, Hornberger LK et al (2014) Diagnosis and treatment of fetal cardiac disease: a scientific statement from the American Heart Association. Circulation 129:2183\u20132242. https:\/\/doi.org\/10.1161\/01.cir.0000437597.44550.5d","journal-title":"Circulation"},{"key":"8092_CR19","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3760\/cma.j.cn112138-20220821-00612inChinese","volume":"14","author":"XP Tian","year":"2023","unstructured":"Tian XP, Zhao JL, Li MT, Song YJ, Liu JT, Zeng XF (2023) Interpretation on the 2022 Chinese guideline for the management of pregnancy and reproduction in patients with systemic lupus erythematous. Med J Peking Union Med Coll Hosp 14:504\u2013513. https:\/\/doi.org\/10.3760\/cma.j.cn112138-20220821-00612inChinese","journal-title":"Med J Peking Union Med Coll Hosp"},{"key":"8092_CR20","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76:476\u2013485. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"key":"8092_CR21","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1016\/S2665-9913(19)30069-4","volume":"1","author":"N Costedoat-Chalumeau","year":"2019","unstructured":"Costedoat-Chalumeau N, Morel N, Fischer-Betz R et al (2019) Routine repeated echocardiographic monitoring of fetuses exposed to maternal anti-SSA antibodies: time to question the dogma. Lancet Rheumatol 1:e187\u2013e193. https:\/\/doi.org\/10.1016\/S2665-9913(19)30069-4","journal-title":"Lancet Rheumatol"},{"key":"8092_CR22","doi-asserted-by":"publisher","first-page":"761.e1","DOI":"10.1016\/j.ajog.2022.05.071","volume":"227","author":"AM Kaizer","year":"2022","unstructured":"Kaizer AM, Lindblade C, Clancy R et al (2022) Reducing the burden of surveillance in pregnant women with no history of fetal atrioventricular block using the negative predictive value of anti-Ro\/SSA antibody titers. Am J Obstet Gynecol 227:761.e1-761.e10. https:\/\/doi.org\/10.1016\/j.ajog.2022.05.071","journal-title":"Am J Obstet Gynecol"},{"key":"8092_CR23","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1177\/0961203315593171","volume":"24","author":"J Tingstr\u00f6m","year":"2015","unstructured":"Tingstr\u00f6m J, Hjelmstedt A, Welin Henriksson E et al (2015) Ro\/SSA autoantibody-positive pregnancy: reactions to serial fetal Doppler echocardiographic surveillance. Lupus 24:1540\u20131545. https:\/\/doi.org\/10.1177\/0961203315593171","journal-title":"Lupus"},{"key":"8092_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2129","author":"JF Strasburger","year":"2022","unstructured":"Strasburger JF, Eckstein G, Butler M et al (2022) Fetal arrhythmia diagnosis and pharmacologic management. J Clin Pharma. https:\/\/doi.org\/10.1002\/jcph.2129","journal-title":"J Clin Pharma"},{"key":"8092_CR25","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1365-3083.2010.02434.x","volume":"72","author":"S-E Sonesson","year":"2010","unstructured":"Sonesson S-E (2010) Diagnosing foetal atrioventricular heart blocks. Scand J Immunol 72:205\u2013212. https:\/\/doi.org\/10.1111\/j.1365-3083.2010.02434.x","journal-title":"Scand J Immunol"},{"key":"8092_CR26","doi-asserted-by":"publisher","first-page":"600","DOI":"10.5935\/abc.20190075","volume":"112","author":"SRFF Pedra","year":"2019","unstructured":"Pedra SRFF, Zielinsky P, Binotto CN et al (2019) Brazilian fetal cardiology guidelines - 2019. Arq Bras Cardiol 112:600\u2013648. https:\/\/doi.org\/10.5935\/abc.20190075","journal-title":"Arq Bras Cardiol"},{"key":"8092_CR27","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/s0029-7844(00)01007-3","volume":"96","author":"JC Fouron","year":"2000","unstructured":"Fouron JC, Proulx F, Mir\u00f3 J, Gosselin J (2000) Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 96:732\u2013736. https:\/\/doi.org\/10.1016\/s0029-7844(00)01007-3","journal-title":"Obstet Gynecol"},{"key":"8092_CR28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/s0002-9149(00)00867-5","volume":"86","author":"JS Glickstein","year":"2000","unstructured":"Glickstein JS, Buyon J, Friedman D (2000) Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 86:236\u2013239. https:\/\/doi.org\/10.1016\/s0002-9149(00)00867-5","journal-title":"Am J Cardiol"},{"key":"8092_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4103\/apc.APC_134_17","volume":"11","author":"NJ Bravo-Valenzuela","year":"2018","unstructured":"Bravo-Valenzuela NJ, Rocha LA, Machado Nardozza LM, Araujo J\u00fanior E (2018) Fetal cardiac arrhythmias: current evidence. Ann Pediatr Cardiol 11:148\u2013163. https:\/\/doi.org\/10.4103\/apc.APC_134_17","journal-title":"Ann Pediatr Cardiol"},{"key":"8092_CR30","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1136\/hrt.2006.093070","volume":"92","author":"M Nii","year":"2006","unstructured":"Nii M, Hamilton RM, Fenwick L et al (2006) Assessment of fetal atrioventricular time intervals by tissue Doppler and pulse Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart 92:1831\u20131837. https:\/\/doi.org\/10.1136\/hrt.2006.093070","journal-title":"Heart"},{"key":"8092_CR31","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1161\/CIRCULATIONAHA.108.773143","volume":"119","author":"AJJT Rein","year":"2009","unstructured":"Rein AJJT, Mevorach D, Perles Z et al (2009) Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA\/Ro-SSB\/La antibodies: a prospective, observational, fetal kinetocardiogram-based study. Circulation 119:1867\u20131872. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.773143","journal-title":"Circulation"},{"key":"8092_CR32","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/uog.7333","volume":"34","author":"A Wojakowski","year":"2009","unstructured":"Wojakowski A, Izbizky G, Carcano ME et al (2009) Fetal Doppler mechanical PR interval: correlation with fetal heart rate, gestational age and fetal sex. Ultrasound Obstet Gyne 34:538\u2013542. https:\/\/doi.org\/10.1002\/uog.7333","journal-title":"Ultrasound Obstet Gyne"},{"key":"8092_CR33","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/14767050410001699866","volume":"15","author":"A Bolnick","year":"2004","unstructured":"Bolnick A, Borgida A, Egan J, Zelop C (2004) Influence of gestational age and fetal heart rate on the fetal mechanical PR interval. J Matern Fetal Neonatal Med 15:303\u2013305. https:\/\/doi.org\/10.1080\/14767050410001699866","journal-title":"J Matern Fetal Neonatal Med"},{"key":"8092_CR34","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","volume":"44","author":"A Brucato","year":"2001","unstructured":"Brucato A, Frassi M, Franceschini F et al (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44:1832\u20131835. https:\/\/doi.org\/10.1002\/1529-0131(200108)44:8%3c1832::AID-ART320%3e3.0.CO;2-C","journal-title":"Arthritis Rheum"},{"key":"8092_CR35","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1002\/art.20126","volume":"50","author":"S Sonesson","year":"2004","unstructured":"Sonesson S, Salomonsson S, Jacobsson L et al (2004) Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti\u2013SSA\/Ro 52-kd antibodies. Arthritis Rheum 50:1253\u20131261. https:\/\/doi.org\/10.1002\/art.20126","journal-title":"Arthritis Rheum"},{"key":"8092_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","volume":"117","author":"DM Friedman","year":"2008","unstructured":"Friedman DM, Kim MY, Copel JA et al (2008) Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and dexamethasone evaluation (PRIDE) prospective study. Circulation 117:485\u2013493. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.707661","journal-title":"Circulation"},{"key":"8092_CR37","first-page":"783","volume":"38","author":"A Hoxha","year":"2020","unstructured":"Hoxha A, Mattia E, Zanetti A et al (2020) Fluorinated steroids are not superior to any treatment to ameliorate the outcome of autoimmune mediated congenital heart block: a systematic review of the literature and meta-analysis. Clin Exp Rheumatol 38:783\u2013791","journal-title":"Clin Exp Rheumatol"},{"key":"8092_CR38","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000513202","volume":"48","author":"M Saito","year":"2021","unstructured":"Saito M, Silverman E, Golding F et al (2021) Effects of transplacental dexamethasone therapy on fetal immune-mediated complete heart block. Fetal Diagn Ther 48:183\u2013188. https:\/\/doi.org\/10.1159\/000513202","journal-title":"Fetal Diagn Ther"},{"key":"8092_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.121.023000","volume":"11","author":"W Mawad","year":"2022","unstructured":"Mawad W, Hornberger L, Cuneo B et al (2022) Outcome of antibody-mediated fetal heart disease with standardized anti-inflammatory transplacental treatment. J Am Heart Assoc 11:e023000. https:\/\/doi.org\/10.1161\/JAHA.121.023000","journal-title":"J Am Heart Assoc"},{"key":"8092_CR40","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","volume":"22","author":"A Saxena","year":"2014","unstructured":"Saxena A, Izmirly PM, Mendez B et al (2014) Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol Rev 22:263\u2013267. https:\/\/doi.org\/10.1097\/CRD.0000000000000026","journal-title":"Cardiol Rev"},{"key":"8092_CR41","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.amjcard.2008.12.027","volume":"103","author":"DM Friedman","year":"2009","unstructured":"Friedman DM, Kim MY, Copel JA et al (2009) Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 103:1102\u20131106. https:\/\/doi.org\/10.1016\/j.amjcard.2008.12.027","journal-title":"Am J Cardiol"},{"key":"8092_CR42","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1177\/0961203311430969","volume":"21","author":"A Ruffatti","year":"2012","unstructured":"Ruffatti A, Milanesi O, Chiandetti L et al (2012) A combination therapy to treat second-degree anti-Ro\/La-related congenital heart block: a strategy to avoid stable third-degree heart block? Lupus 21:666\u2013671. https:\/\/doi.org\/10.1177\/0961203311430969","journal-title":"Lupus"},{"key":"8092_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.autrev.2013.01.002","volume":"12","author":"A Ruffatti","year":"2013","unstructured":"Ruffatti A, Marson P, Svaluto-Moreolo G et al (2013) A combination therapy protocol of plasmapheresis, intravenous immunoglobulins and betamethasone to treat anti-Ro\/La-related congenital atrioventricular block. A case series and review of the literature. Autoimmun Rev 12:768\u2013773. https:\/\/doi.org\/10.1016\/j.autrev.2013.01.002","journal-title":"Autoimmun Rev"},{"key":"8092_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1093\/eurjhf\/hfq198","volume":"13","author":"H Xiao","year":"2011","unstructured":"Xiao H, Wang M, Du Y et al (2011) Arrhythmogenic autoantibodies against calcium channel lead to sudden death in idiopathic dilated cardiomyopathy. Eur J Heart Fail 13:264\u2013270. https:\/\/doi.org\/10.1093\/eurjhf\/hfq198","journal-title":"Eur J Heart Fail"},{"key":"8092_CR45","doi-asserted-by":"publisher","first-page":"e202417","DOI":"10.21542\/gcsp.2024.17","volume":"2024","author":"H Farhat","year":"2024","unstructured":"Farhat H, Kassab CJ, Tlaiss Y et al (2024) Hydroxychloroquine and the associated risk of arrhythmias. Glob Cardiol Sci Pract 2024:e202417. https:\/\/doi.org\/10.21542\/gcsp.2024.17","journal-title":"Glob Cardiol Sci Pract"},{"key":"8092_CR46","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1093\/rheumatology\/kex191","volume":"56","author":"J Barsalou","year":"2017","unstructured":"Barsalou J, Jaeggi E, Laskin CA et al (2017) Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort study. Rheumatology 56:1552\u20131559. https:\/\/doi.org\/10.1093\/rheumatology\/kex191","journal-title":"Rheumatology"},{"key":"8092_CR47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.5114\/ada.2022.122601","volume":"39","author":"A Liszewska","year":"2022","unstructured":"Liszewska A, Wo\u017aniacka A (2022) Neonatal lupus erythematosus-prevention is better than cure. Postepy Dermatol Alergol 39:1021\u20131026. https:\/\/doi.org\/10.5114\/ada.2022.122601","journal-title":"Postepy Dermatol Alergol"},{"key":"8092_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739605","volume":"12","author":"H Li","year":"2021","unstructured":"Li H, Gao Y, Xie L et al (2021) Prednisone reprograms the transcriptional immune cell landscape in CNS autoimmune disease. Front Immunol 12:739605. https:\/\/doi.org\/10.3389\/fimmu.2021.739605","journal-title":"Front Immunol"},{"key":"8092_CR49","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1080\/14740338.2021.1893298","volume":"20","author":"AV Taulaigo","year":"2021","unstructured":"Taulaigo AV, Moschetti L, Ganh\u00e3o S et al (2021) Safety considerations when using drugs in pregnant patients with systemic lupus erythematosus. Expert Opin Drug Saf 20:523\u2013536. https:\/\/doi.org\/10.1080\/14740338.2021.1893298","journal-title":"Expert Opin Drug Saf"},{"key":"8092_CR50","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/s0029-7844(99)00006-x","volume":"93","author":"K Shinohara","year":"1999","unstructured":"Shinohara K, Miyagawa S, Fujita T et al (1999) Neonatal lupus erythematosus: results of maternal corticosteroid therapy. Obstet Gynecol 93:952\u2013957. https:\/\/doi.org\/10.1016\/s0029-7844(99)00006-x","journal-title":"Obstet Gynecol"},{"key":"8092_CR51","doi-asserted-by":"publisher","first-page":"64.e1","DOI":"10.1016\/j.ajog.2012.09.020","volume":"208","author":"RD Tunks","year":"2013","unstructured":"Tunks RD, Clowse MEB, Miller SG et al (2013) Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am J Obstet Gynecol 208:64.e1-64.e7. https:\/\/doi.org\/10.1016\/j.ajog.2012.09.020","journal-title":"Am J Obstet Gynecol"},{"key":"8092_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11926-007-0003-4","volume":"9","author":"DM Friedman","year":"2007","unstructured":"Friedman DM, Rupel A, Buyon JP (2007) Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep 9:101\u2013108. https:\/\/doi.org\/10.1007\/s11926-007-0003-4","journal-title":"Curr Rheumatol Rep"},{"key":"8092_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.55563\/clinexprheumatol\/2ju0yv","volume":"41","author":"M Fredi","year":"2023","unstructured":"Fredi M, Argolini LM, Angeli F et al (2023) Anti-SSA\/Ro positivity and congenital heart block: obstetric and foetal outcome in a cohort of anti-SSA\/Ro positive pregnant patients with and without autoimmune diseases. Clin Exp Rheumatol 41:685\u2013693. https:\/\/doi.org\/10.55563\/clinexprheumatol\/2ju0yv","journal-title":"Clin Exp Rheumatol"},{"key":"8092_CR54","first-page":"1","volume":"44","author":"GH Tian","year":"2022","unstructured":"Tian GH, Guo J, Liu M, Wu QM, Ling W, Wen ZJ (2022) Ultrasonic presentation and pregnancy outcome of immune-mediated fetal cardiac anomalies. Fujian Med J 44:1\u20135 (in Chinese)","journal-title":"Fujian Med J"},{"key":"8092_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-000989","volume":"6","author":"M Hedlund","year":"2020","unstructured":"Hedlund M, Thorlacius GE, Ivanchenko M et al (2020) Type I IFN system activation in newborns exposed to Ro\/SSA and La\/SSB autoantibodies in utero. RMD Open 6:e000989. https:\/\/doi.org\/10.1136\/rmdopen-2019-000989","journal-title":"RMD Open"},{"key":"8092_CR56","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/uog.7532","volume":"36","author":"G Bergman","year":"2010","unstructured":"Bergman G, Wahren-Herlenius M, Sonesson S-E (2010) Diagnostic precision of Doppler flow echocardiography in fetuses at risk for atrioventricular block. Ultrasound Obstet Gyne 36:561\u2013566. https:\/\/doi.org\/10.1002\/uog.7532","journal-title":"Ultrasound Obstet Gyne"},{"key":"8092_CR57","first-page":"1094","volume":"33","author":"YN Yan","year":"2017","unstructured":"Yan YN, Wei JL, Li YT, Yang ZJ, Wu JH, Pei QY (2017) Prenatal ultrasonographic analysis of immune related fetal heart disease. Chin J Ultrasound Med 33:1094\u20131096 (in Chinese)","journal-title":"Chin J Ultrasound Med"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08092-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08092-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08092-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:53:15Z","timestamp":1755935595000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08092-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["8092"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08092-6","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}